News

Jennifer Maynard was among the grant recipients at The University of Texas at Austin in a round of CPRIT awards.

For his role in biomedical research linked to the development of vaccines and treatments for COVID-19, the professor of molecular biosciences won the award given annually by the State Bar of Texas's Intellectual Property Section in recognition of an individual whose invention "has significantly impacted the Texas economy."

Most antibodies against SARS-CoV-2 circulating in the blood target areas of the viral spike protein outside the receptor binding domain, or RBD

A COVID-19 vaccine in human trials in Vietnam, Thailand and Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines.

The world’s largest multidisciplinary scientific society has announced that Jason McLellan, a University of Texas at Austin associate professor in the Department of Molecular Biosciences, and Daniel Wrapp, a graduate student fellow, were among seven winners of this year’s Golden Goose Award.

The virus that causes COVID-19 is accumulating genetic mutations, one of which may have made it more contagious.

A redesigned version of the coronavirus spike protein called HexaPro might speed up vaccine production and yield a more effective immune response to SARS-CoV-2.

The hunt for an effective treatment for COVID-19 has led researchers to find an improbable ally for their work: a llama named Winter.

Genetically engineered strains of bacteria protect bees from mites and viruses that can lead to colony collapse.

Here are a handful of ways that members of our science and mathematics community brandished their entrepreneurial spirit this year.